Literature DB >> 8189541

FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

A Azoulay1, M Brahic, J F Bureau.   

Abstract

The DA strain of Theiler's virus causes a persistent infection of the white matter of the spinal cord with chronic inflammation and primary demyelination. Inbred strains of mice differ greatly in their susceptibility to this disease. It has been shown that both viral persistence and demyelination are controlled mainly by a gene located in the H-2D region. This raised the possibility that the H-2D gene itself controls viral persistence, which in turn determines demyelination. In the present work we introduced the H-2Db gene of resistant C57BL/6 mice into the genome of susceptible H-2q FVB mice and showed that the FVB mice become resistant to persistence of the infection and did not develop inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189541      PMCID: PMC236915     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites.

Authors:  H Allen; D Wraith; P Pala; B Askonas; R A Flavell
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

3.  Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice.

Authors:  A K Patick; L R Pease; C S David; M Rodriguez
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  FVB/N: an inbred mouse strain preferable for transgenic analyses.

Authors:  M Taketo; A C Schroeder; L E Mobraaten; K B Gunning; G Hanten; R R Fox; T H Roderick; C L Stewart; F Lilly; C T Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Theiler's virus infection induces a specific cytotoxic T lymphocyte response.

Authors:  C Pena Rossi; A McAllister; L Fiette; M Brahic
Journal:  Cell Immunol       Date:  1991-12       Impact factor: 4.868

6.  Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.

Authors:  H L Lipton; R Melvold
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

7.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 8.  MHC class-I transgenic mice.

Authors:  B Arnold; G J Hämmerling
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

Authors:  R J Clatch; R W Melvold; S D Miller; H L Lipton
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

10.  Demyelination induced by Theiler's virus: influence of the H-2 haplotype.

Authors:  M Rodriguez; C S David
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

View more
  45 in total

1.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice.

Authors:  F Bihl; M Brahic; J F Bureau
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

3.  Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the beta(2)m gene.

Authors:  S Aubagnac; M Brahic; J F Bureau
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

6.  An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.

Authors:  S Dethlefs; M Brahic; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.

Authors:  Yanice V Mendez-Fernandez; Michael J Hansen; Moses Rodriguez; Larry R Pease
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.

Authors:  Zachariah P Tritz; Robin C Orozco; Courtney S Malo; Katayoun Ayasoufi; Cori E Fain; Roman H Khadka; Emma N Goddery; Lila T Yokanovich; Megan L Settell; Michael J Hansen; Fang Jin; Kevin D Pavelko; Larry R Pease; Aaron J Johnson
Journal:  J Immunol       Date:  2020-07-31       Impact factor: 5.422

Review 9.  Neuroimmune interactions in a model of multiple sclerosis.

Authors:  C Jane Welsh; Andrew J Steelman; Wentao Mi; Colin R Young; Ralph Storts; Thomas H Welsh; Mary W Meagher
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 10.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.